Bloomberg Businessweek
Once hailed as the future of medicine, gene therapies are losing the confidence of pharma giants and investors as costs mount and commercial returns disappoint.
October 2024 · 14 min read
Bloomberg Businessweek
As baby boomers age into greater medical need, a strained workforce of doctors, nurses and aides faces a widening gap that threatens patient care.
August 2023 · 8 min read
Bloomberg
As vaccine skepticism reaches the highest levels of U.S. health policy, anxious parents are pressing pediatricians to move up their children's immunizations.
July 2025 · 15 min read
Bloomberg Businessweek
Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.
May 2026 · 20 min read
Bloomberg
Regeneron's one-time treatment for a rare inherited form of deafness marks a milestone for gene therapy — and offers new hope to families of children born unable to hear.
April 2026 · 12 min read
Bloomberg Businessweek
Drugmakers have delivered long-promised one-shot cures — but a thin pipeline of eligible patients is forcing a hard rethink of the gene therapy business.
February 2024 · 16 min read
Bloomberg
As Leqembi rolls out to patients, a small but troubling number of deaths is forcing doctors to confront harder questions about who should — and shouldn't — receive the drug.
March 2025 · 22 min read
Bloomberg
Moderna bet its mRNA platform could leapfrog rivals in the race to protect older adults from RSV. The data tell a more complicated story.
May 2024 · 16 min read
Bloomberg
A new class of painkillers promises relief without the risk of addiction. The catch: pricing that could put them out of reach for the patients who need them most.
July 2024 · 12 min read
Bloomberg
As million-dollar gene therapies reach the market, some employers are drawing a hard line — leaving workers and their families to fight for access to treatments that could save their lives.
September 2024 · 18 min read
Bloomberg
A former NFL punter turned podcaster parlays an unconventional media playbook — and a massive FanDuel pact — into a perch at the center of football culture.
January 2022 · 10 min read